Breast Cancer
- Home
- Breast Cancer
Breast Cancer – Understanding, Treating, and Advancing Hope Through Cell Therapy
Breast cancer is the most commonly diagnosed cancer among women worldwide, including in Malaysia. While early detection and conventional treatment options such as surgery, chemotherapy, and radiation have significantly improved survival rates, there is still a strong need for more targeted, less toxic, and longer-lasting treatment options — especially for advanced and recurrent cases.
At RCERT (Regional Cell Research & Therapy Centre), we are exploring the frontiers of cell-based therapies, including Natural Killer (NK) Cells, Dendritic Cell (DC) Therapy, and DC-CIK or DC-CTL combinations, to offer new hope for breast cancer patients through personalized immunotherapy.
🎗️ What is Breast Cancer?
Breast cancer is a disease where cells in the breast grow uncontrollably. It can start in different parts of the breast, most commonly in the ducts (ductal carcinoma) or lobules (lobular carcinoma). Over time, it may spread to nearby tissues or distant organs if not treated promptly.
While breast cancer primarily affects women, it can also occur in men, although rarely.
📊 Breast Cancer in Malaysia
Breast cancer is the most common cancer among women in Malaysia, accounting for nearly 1 in 5 female cancer diagnoses.
According to national statistics, more than 50% of Malaysian breast cancer cases are diagnosed at Stage III or IV.
Younger women (under 40) are increasingly being diagnosed, often with more aggressive subtypes.
This highlights the importance of early detection, regular screening, and access to advanced treatment options.
🧬 Types of Breast Cancer
Hormone Receptor-Positive (HR+):
Estrogen Receptor (ER) or Progesterone Receptor (PR) positive
Treated with hormone therapy and targeted drugs
HER2-Positive:
Overexpression of the HER2 gene
Responsive to HER2-targeted therapies (e.g., trastuzumab)
Triple-Negative Breast Cancer (TNBC):
Lacks ER, PR, and HER2
More aggressive, with fewer targeted options
Often considered for immunotherapy or clinical trials
🧪 Standard Treatment Options
Surgery: Lumpectomy or mastectomy
Radiation therapy
Chemotherapy
Targeted therapy (HER2 inhibitors, CDK4/6 inhibitors)
Hormonal therapy (for HR+ cancers)
While these treatments are effective for many, they may lead to side effects such as fatigue, hair loss, nausea, immune suppression, and long-term hormonal imbalance.
🧠 Why Cell Therapy for Breast Cancer?
Cell therapy represents a new, promising avenue for breast cancer treatment — especially for patients with:
Advanced or metastatic disease
Tumors resistant to chemotherapy
Recurrence after surgery
Triple-negative breast cancer
A desire for less toxic and more personalized treatments
🔬 RCERT’s Cell-Based Therapy for Breast Cancer
At RCERT, we offer investigational and supportive care options that focus on harnessing the patient’s immune system to fight cancer:
1. Natural Killer (NK) Cell Therapy
Targets and destroys cancer cells non-specifically
Safe and effective for immune-boosting and recurrence prevention
Especially useful post-chemotherapy to restore immunity
2. Dendritic Cell (DC) Therapy
Activates the immune system by presenting breast cancer antigens
Trains T cells to recognize and destroy tumor cells
Safe, minimally invasive, and highly customizable
3. DC-CIK or DC-CTL Combinations
Combines DC’s antigen-targeting power with cytotoxic T cells or CIK cells
Broader killing capacity, suitable for resistant or aggressive tumors
Can enhance immune surveillance and long-term control
✅ Benefits of Cell Therapy for Breast Cancer
Personalized & Targeted: Based on patient’s immune profile and tumor type
Minimal Side Effects: No hair loss, nausea, or immune suppression
Immune Memory Formation: May prevent recurrence
Supports Recovery: Can be used after chemo/surgery for faster immune regeneration
Compatible with Conventional Therapy: Can be integrated or used post-treatment
🧬 Research & International Collaboration
RCERT collaborates with:
UNIMAS Malaysia – for academic and clinical research
Zhongrong Cell Technology Center, China – for technology transfer and protocol standardization
We are also preparing to launch clinical trials specifically targeting HER2-positive and triple-negative breast cancer, integrating DNA methylation testing and immune cell profiling.
⚖️ Is Cell Therapy Safe?
Yes. All cell therapies at RCERT are performed in a GMP-certified laboratory under the supervision of trained medical professionals.
Side effects are minimal and typically limited to:
Low-grade fever
Mild fatigue
Localized inflammation (temporary)
Patients are monitored pre- and post-infusion to ensure safety and optimal outcomes.
👥 Who Should Consider Cell Therapy?
Cell-based therapy may be suitable for:
Patients with Stage III or IV breast cancer
Patients with triple-negative or HER2-positive subtypes
Those who have completed chemotherapy or surgery
Individuals looking for complementary or integrative care
Patients interested in preventive recurrence strategies
A medical evaluation and immune profile analysis will be conducted to assess eligibility.
📍 Breast Cancer Care at RCERT
We believe in treating not just the disease, but the whole person. RCERT offers:
Personalized consultations
Immune health assessments
Tailored therapy plans
Follow-up support and immune monitoring
Integration with anti-aging and wellness programs
Our goal is to empower patients with effective, science-backed, and compassionate care.
📝 Conclusion
Breast cancer affects thousands of women in Malaysia every year, but with early detection and access to advanced therapies like cell therapy, patients can now look forward to more options — not just for treatment, but for long-term wellness and survival.
At RCERT, we are proud to lead the way in immunotherapy and regenerative medicine, offering new hope to women facing breast cancer through precision science and personalized care.
📞 Contact us today to schedule your consultation or learn more about breast cancer treatment options with cell therapy.